Foodconsumer.org

 
USCards.com Bookmark Us
All Food, Diet and Health News 
 
 Misc. News
 Must-Read News
 Letter to Editor
 Featured Products
 Recalls & Alerts
 Consumer Affair
 Non-food Things
 Health Tips
 Interesting Sites
 
 Diet & Health
 Heart & Blood
 Cancer
 Body Weight
 Children & Women
 General Health
 Nutrition
 
 Food & Health
 Food Chemicals
 Biological Agents
 Cooking & Packing
 Technologies
 Agri. & Environ.
 Laws & Politics
 
 General Health
 Drug News
 Diseases
 Mental Health
 Infectious Disease
 Environment
 Lifestyle
 Government
 Other News
 
 Food Consumer
 FC News & Others
Search





Search Foodconsumer & Others


Add to Google
Add to My Yahoo
Newsfeed

foodconsumer.org news feed
Su bmit news[release]



More than 100 credit cards available at uscards.com from uscards.com, you can pick more than 100 credit cards


General Health : Other News Last Updated: May 5, 2009 - 12:58:27 PM


Dallas lawyer Fred Baron obtains unapproved cancer drug
By Ben Wasserman
Oct 17, 2008 - 12:23:32 PM

E.mail t.his a.rticle
 P.rinter f.riendly p.age
Get n.ewsletter
 
   

Vita.min C lowers blo.od pre.ssure


Friday October 17 2008 (foodconsumer.org) -- A democratic fundraiser has obtained an experimental cancer-fighting drug through the Mayo Clinic although initially the drug maker refused to give it because the drug has not been approved to treat the disease he is suffering.

 

Fred Baron, a prominent political donor for the Democratic Party, obtained Tysabri finally after legal basis was found that he can be given the drug, his son Andrew Baron was cited as saying in an e-mail to theassociatedpress.

 

Baron said Tysabri is the last resort for treatment of his 61-year-old father's late-stage multiple myeloma for which the older Baron was given a few to live.

 

Tysabri was initiated approved by the Food and Drug Administration in November 2004 to treat multiple sclerosis or MS. It was withdrawn by the manufacturer Biogen-Idec in Feb 2005 after three patients in a trial was found to have develop progressive multifocal leukoencephalopathy (PML), a serious and rare viral infection of the brain.

 

The FDA approved in June 5 2006 an application for resumed marketing of Tysabri, but a special restricted distribution program is required to decrease the possibility of patients developing PML in the future.

 

But this drug has not been approved to treat multiple myeloma and a clinical trial is ongoing in its early stage.

 

Under certain circumstances, however, patients may seek to use drugs unapproved by the FDA as long as it is used as single-patient investigations, but permission should be granted by the drug maker.

 

Biogen Idec Inc. refused even later on Thursday to give the permission for Fred Baron to use its drug citing the high regulatory risks of giving an individual special access to Tysabri. The company resisted appeal from former president Bill Clinton and Lance Armstrong, a cancer survivor.

 

Andrew Baron said the Mayo Clinic found a legal ground for his father to use the drug, but Mayo Clinic spokesman John Murphy was cited as saying he was not aware of such a case.

 

Each year in the United States, about 15,000 people are diagnosed with multiple myeloma, a form of cancer. Doctors do not know what causes the disease.   But studies are being conducted to determine the effect of radiation, pesticide, hair dye, certain viruses, obesity and diet.





© 2004-2008 by foodconsumer.org unless otherwise specified

Top of Page




Google
 
Web foodconsumer.org

Search Consumer-friendly Health Sites












We have moved to Food Consumer . Org



disclaimer | advertising | jobs | privacy | about us | newsletter | Submit news/articles
link partners: | Buy Viagra | MarketAmerica.com |
Buy a home | Auto Insurance | Mortgage refinancing | DaytonaCPA.com | Take Your Blog to a Higher Level
© Copyright 2004 - 2008 foodconsumer.org All rights reserved

Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only. The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals. Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.